evidence suggest that SR protein family also regulates RNA elongation (3), transport (4) , and translation (5), suggesting a wide-ranging role in gene expression. In addition, SRSF3 is overexpressed in human ovarian cancer, and its knockdown results in apoptosis of ovarian cancer cells (6) . Recently, we have shown that reduction of SRSF3 causes G1 cell cycle arrest and apoptosis in colon cancer cells (7) . These findings suggest that SRSF3 may be one of the essential factors for regulation of cell fate.
The human SRSF3 gene is composed of 7 exons and generates two mRNA isoforms. Like other SRSF family member genes, the human SRSF3 gene contains an element of extreme sequence conservation, termed "ultraconserved element" (UCE). SRSF3 contains a 577-bp UCE that includes entire exon 4, and this exon 4 has multiple premature termination codons (PTCs) . A major SRSF3 mRNA isoform encoding a functional full-length SRSF3 protein (SRSF3-FL) excludes this exon 4. Alternative splicing of SRSF3 pre-mRNA produces another mRNA isoform consisting of entire 7 exons. This PTC-containing SRSF3 isoform (SRSF3-PTC ) is considered to be degraded through the nonsensemediated mRNA decay (NMD) system, a surveillance mechanism that decomposes PTC-containing mRNAs. However, it was reported that SRSF3-PTC mRNA was translated into a truncated SRSF3 protein (SRSF3-TR) partially lacking RS domain in the murine B-cell lymphoma K46 cells (8) . We also found that colon cancer cells (HCT116) induced SRSF3-TR in response to sodium arsenite (unpublished observations). At present, however, the biological function of SRSF3-TR is unknown.
In this study, we established Flp-In-293 cells stably expressing SRSF3-TR, and showed that SRSF3-TR facilitated cell growth through up-regulating c-Jun expression.
MATERIALS AND METHODS

Cell culture and cell counting
Flp-In-293 cells (Invitrogen, Carlsbad, CA) were maintained in high-glucose Dulbecco's modified Eagle's medium (Nacalai tesque, Kyoto, Japan) supplemented with 10% (v/v) heat-inactivated fetal calf serum, 2 mM l-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin in a humidified atmosphere of 5% CO2 in air. Numbers of growing cells were counted manually using a hematocytometer.
Plasmid construction
Using a cDNA library prepared from a human colon cancer cell line (HCT116), the human SRSF3-PTC mRNA (Ensembl Transcript ID : ENST00000477442) were amplified by PCR using a primer set : 5'-AAAAAAGGATCCATGCATCGT-GATTCCTGTCCATTG-3' (forward, BamHI site is underlined) and 5'-AAAAAAGATATCCTATTTCC-TTTCATTTGACCTAGA-3' (reverse, EcoRV site is underlined). The amplified product was cloned into the mammalian expression vector pCMV-3Tag (pCMV-3Tag/SRSF3-TR ; Stratagene, La Jolla, CA). FLAG was appended to the NH2 termini of SRSF3. Subsequently, PCR was performed using the pCMV3Tag/SRSF3-TR plasmid as the template and the following primer set : 5'-AAAAAAGGTACCGCCA-CCATGGATTACAAGGA-3' (forward, KpnI site is underlined) and the same reverse primer used for amplification of SRSF3-PTC mRNA. The amplified products were cloned into the pcDNA5/FRT vector (pcDNA5/FRT-3xFLAG-SRSF3-TR). All constructs were confirmed to have the expected sequence by DNA sequencing. The plasmid was transfected using FuGENE HD (Promega, Madison, WI) according to the manufacturer's instructions.
Establishment of a cell line stably expressing SRSF3-TR
Flp-In-293 cells were co-transfected with the pcDNA5/FRT-3xFLAG-SRSF3-TR vector and a Flp recombinase expression plasmid pOG44 according to the manufacturer's protocol of the Flp-In system (Invitrogen). A single colony resistant to hygromycin B (Invitrogen) was selected and subcultured. Selection of positive colonies (293/SRFS3-TR) was performed by Western blotting using an anti-SRSF3 antibody. Flp-In-293 cells were transfected with pcDNA5/FRT-3xFLAG-mock and pOG44 vectors (293/mock cells) and used as a control.
Quantitative real-time reverse transcription-PCR (qPCR)
Total RNA was extracted from 293/SRSF3-TR or 293/mock cells using an RNAiso plus (Takara, Otsu, Japan). One microgram of isolated RNA was reverse-transcribed using ReverTra Ace reverse transcriptase (TOYOBO, Osaka, Japan). Primer sequences are shown in Table 1 . Target mRNA levels were measured using SYBR green master mix and the 7500 real-time system (Applied Biosystems, Foster City, CA). Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA and 18S were measured as internal controls for normalization. Using the ΔΔCt method, data are presented as fold changes in mRNA levels relative to those in 293/ mock cells.
Western blotting
Whole-cell lysates were prepared in RIPA buffer (10 mM Tris-HCl, pH 7.4 ; 150 mM NaCl ; 1 mM EDTA ; 1 mM DTT ; 0.1% sodium dodecyl sulfate ; 1% Nonidet P-40) containing a protease and phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). The extracted proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane (BioRad, Hercules, CA). After blocking with 5% non-fat dry milk, the membranes were incubated overnight at 4! ! with a mouse monoclonal anti-SRSF3 (1 : 1000 dilution, Sigma-Aldrich), anti-FLAG (1 : 1000, Sigma-Aldrich), anti-cyclin D1 (1 : 1000, Cell Signaling Tech., Danvers, MA), anticyclin D3 (1 : 1000, Cell Signaling Tech.), anti-cyclin E (1 : 1000, Santa Cruz Biotech., Santa Cruz, CA), anti-CDC25A (1 : 1000, Cell Signaling Tech.), anti-E2F1 (1 : 1000, Cell Signaling Tech.), anti-cJun (1 : 1000 ; Cell Signaling Tech.), anti-Sp1 (1 : 1000, Sigma-Aldrich), or anti-GAPDH (1 : 5000 ; Santa Cruz Biotech.) antibody. Following incubation with an appropriate secondary antibody for 1 h at room temperature, bound antibodies were detected with an ECL or ECL Prime Western Blotting Detection System (GE Healthcare, Piscataway, NJ). The membrane was re-blotted using an anti-GAPDH antibody as a loading control.
Promoter activity assay
The 5' flank of the human JUN gene was cloned into the pGL3-basic luciferase reporter vector (Promega). In brief, the first PCR was performed using the human genomic DNA as a template. The JUN proximal promoter region (from -1,266 to +170 bp) was amplified using the following primer set : 5'-AAAAAGGTACCTTACATGTGTCTAGCGCTTC-3' (forward) and 5'-AAAAACTCGAGGGGAGCCA-CAGGCGCTAGCTCT-3' (reverse). Subsequently, the amplified product was used as a template to generate deletion constructs consisting of the -798 to +170 bp, -331 to +170 bp, and -32 to +170 bp regions using the same reverse primer and one of the following forward primers : 5'-AAAAAGGTACCTC-TCGGCTTCTACGAGCAGC-3' for -798 to +170 bp, 5'-AAAAAGGTACCCCAAGACGTCAGCCCACAA-TG-3' for -331 to +170 bp and 5'-AAAAAGGTACC-AGCCAATGGGAAGGCCTTG-3' for -32 to +170 bp. The amplified products were subcloned into the pGL3-basic vector using KpnI and SacI restriction sites. Using FuGENE HD (Promega), pGL-3 luciferase constructs (100 ng) and pRL-CMV vector (50 ng) were co-transfected into 293/mock or 293/ SRFS3-TR cells (7.5 x 10 4 cells) growing on 24-well plates. Twenty-four hours after the transfection, cells were harvested, and the firefly and renilla luciferase activities were measured using the Dual-Luciferase Reporter Assay System (Promega).
RESULTS
Effect of SRSF3-TR on cell growth
To disclose novel function(s) resided in a truncated SRSF3 (SRSF3-TR), we established a cell line stably expressing FLAG-tagged SRSF3-TR using the Flp-In system (Invitrogen). After transfection of Flp-In-293 cells with the vectors encoding 3xFLAG-SRSF3-TR and Flp recombinase, a positive clone (293/SRSF3-TR) was selected. The 293/ SRSF3-TR cells stably expressed similar amounts of both endogenous SRSF3-FL and FLAG-tagged SRSF3-TR ( Figure 1A) . The stable expression of Figure 1A) . Unexpectedly, SRSF3-TR -expressing cells showed significantly accelerated growth, compared with control 293/mock cells ( Figure 1B) .
Effects of SRSF3-TR on expression of genes crucial for G1 to S phase transition
In a previous study, we showed that SRSF3 knockdown caused G1 cell cycle arrest through inhibition of cyclin D/CDK4/6 activation and reduction of E2F1 expression (7) . Based on the data, we compared mRNA and protein levels of cyclins (D1, D3, and E1), E2F1, and CDC25A between 293/SRSF3-TR and 293/mock cells. As shown in Figure 2 , SRSF3-TR-expressing cells significantly up-regulated expression of CCND1, CCND3, CCNE1, E2F1, and CDC25A mRNAs ( Figure 2A ) and increased amounts of cyclin D1, cyclin D3, CDC25A, and E2F1 ( Figure 2B ). The first kinase complexes to become active in G1 phase are cyclin D/CDK4/6 that initiate phosphorylation of retinoblastoma (RB) proteins and release E2F1 from the RB-repressor complex, permitting transcription essential for the G1/S transition. Induction of cyclin D1 is important for the activation of cyclin D/CDK4/6. We, therefore, focused on the mechanism how SRSF3-TR increased expression of cyclin D1. Several lines of evidence suggest that c-Jun is one of the crucial factor for cyclin D1 expression (9, 10). In fact, 293/ SRSF3-TR cells increased JUN mRNA ( Figure 3A ) and c-Jun protein ( Figure 3B ) levels, compared with 293/mock cells. We also confirmed that the stable expression of SRSF3-TR did not change the stability of JUN mRNA, suggesting that SRSF3-TR might activate transcription of the JUN gene.
Effects of SRSF3-TR on JUN promoter activity
To test whether SRSF3-TR regulated c-Jun expression at the transcriptional level, we cloned the 5'-flank of JUN (from -1,266 to +170 bp), and 293/ SRSF-TR or 293/mock cells were transfected with a luciferase reporter construct containing -1,266/ +170, -798/+170, -331/+170, or -32/+170 bp region of the human JUN promoter ( Figure 5A ). As shown in Figure 4A , 293/SRSF3-TR cells significantly increased the luciferase reporter activity of the -1,266/+170 and -798/+170 bp regions of the JUN promoter, compared with 293/mock cells. The -331/+170 bp construct partially reduced the promoter activity in 293/SRSF3-TR cells, and the -32/ +170 bp region almost completely lost the promoter activity ( Figure 4A ). The -331/-32 bp region contains two AP-1-binding sites (-190 to -183 and -71 to -64) ( Figure 4C) , and the proximal AP-1-binding site is responsible for trans-activation of the JUN promoter by its gene product (11) . Sp-1 is also known as a crucial transcription factor for JUN (12) , and several Sp-1-binding sites are distributed in both -331/-32 bp and -798/-332 bp regions. Moreover, 293/SRSF3-TR significantly induced Sp-1 ( Figure 4B ), suggesting that multiple cis elements distributed in the -798/-32 bp region might be involved in the SRSF3-TR-mediated JUN promoter activity.
DISCUSSION
Alternative splicing is important for generation of protein isoform diversity and for regulation of gene expression program. At the same time, however, up to one-third of alternative splicing of human genes generates PTC-containing mRNAs (13) . All SRSF family member genes produce PTC -containing splice variants, which is coincided with the presence of UCEs (14) . To avoid production of the C-terminally truncated proteins which may have potential dominant-negative or gain-of-function, PTC-containing mRNAs are expected to be degraded by NMD. However, several lines of evidence have shown that NMD activity is often inhibited by stresses, such as hypoxia, amino acid starvation, and generation of reactive oxygen species (15) (16) (17) . Moreover, it has been shown that the impairment of NMD is involved in the oncogenic mechanism (18) . In fact, several cancer cell lines (HCT116, RKO, and HeLa cells) constitutively expressed significant amounts of the SRSF1 PTC variant. For example, HCT116 cells expressed the SRSF1 PTC variant nearly equivalent to the major isoform (data not shown). These PTC variants are believed not to be translatable, whereas SRSF3-TR was documented to be translated from SRSF3-PTC mRNA (8) . We also found that treatment of HCT116 cells with sodium arsenite induced SRSF3-TR possibly through inhibiting NMD (unpublished observations). The inclusion of exon 4 to mature SRSF3 mRNA was reported to occur under serum starvation (8) , and the biological significance of exon 4-inclusion is considered to be an auto-regulatory feedback loop by SRSF3 itself (19) .
To uncover unknown functions of SRSF3-TR, we established a cell line stably expressing SRSF3-TR using the Flp-In system, and found that SRSF3-TRexpressing cells (293/SRSF3-TR) significantly accelerated their growth, compared with control cells (293/mock). As to the mechanism for the accelerated cell growth, 293/SRSF3-TR significantly increased mRNA and protein levels of essential regulators for the G1 to S phase transition, which included cyclin D1, cyclin D3, CDC25A, and E2F1. cJun is required for progression through the G1 phase, the mechanism by which involves transcriptional control of the cyclin D1 gene (CCND1). We also confirmed that SRSF3-TR-expressing cells significantly increased expression of JUN mRNA and induced c-Jun protein without any growth stimulus. c-Jun positively regulates cell proliferation through the induction of CCND1 transcription and the repression of tumor suppressor gene expression and function (20) . The regulatory elements crucial for the human CCND1 transcription contain two AP-1 binding sites and several AP-1 proteins including c-Jun and c-FOS were shown to bind these sites and suggested to stimulate CCND1 transcription (21) (22) (23) . Along with this line, 293/SRSF3-TR cells exhibited a significantly augmented promoter activity of JUN . The proto-oncogene JUN is positively autoregulated by its product, c-Jun/AP-1 (11). It was reported that two AP-1-binding sites (-182 and -64) of the JUN promoter were important for basal activity and dexamethasone-mediated repression of the JUN promoter (24) . The proximal -71 to -64 bp region is responsible for the autoregulation of the JUN promoter activity (11) . Our luciferase reporter assay also indicated the importance of the -331 to -32 bp region for both basal and SRSF3-TR-dependent activities of the JUN promoter. At the same time, however, our results implicated that there might be SRSF3-TR responsive element(s) in the -798 to -332 bp region. In addition to c-Jun, Sp-1 plays an essential role for basal expression of JUN (12) . The -331/-32 bp region of the JUN promoter contains one Sp-1-binding site, and several putative Sp-1-binding sites are scattered in the -798 to -332 bp region. Moreover, Sp-1 was induced in 293/ SRSF3-TR cells. Thus, multiple trans factors and cis elements appear to be involved in the SRSF3-TRmediated transcription of JUN . Further studies are needed to elucidate the mechanism how SRSF3-TR regulates c-Jun expression.
Although the mechanism how SRSF3-TR regulates c-Jun expression remains to be elucidated, our results suggest that a truncated SRSF3 derived from a PTC-containing splice variant of the SRSF3 gene may have a mitogenic property. NMD was often inhibited under certain conditions such as hypoxia and oxidative stress. Cancer tissues are exposed to similar microenviromental conditions, and it has been shown that the impairment of NMD is involved in the oncogenic mechanism (18) . In such situations, SRSF3-TR could be induced and might participate in abnormal cell growth. Further studies are needed to fully elucidate the molecular mechanism for the SRSF3-TR-mediated acceleration of cell growth.
